Cargando…
Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma
BACKGROUND: Angiogenesis is essential for tumour growth and metastasis. There are conflicting reports as to whether microvessel density (MVD) using the endothelial marker CD105 (cluster of differentiation molecule 105) in clear-cell renal cell carcinomas (ccRCC) is associated with prognosis. Recentl...
Autores principales: | Saroufim, A, Messai, Y, Hasmim, M, Rioux, N, Iacovelli, R, Verhoest, G, Bensalah, K, Patard, J-J, Albiges, L, Azzarone, B, Escudier, B, Chouaib, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974088/ https://www.ncbi.nlm.nih.gov/pubmed/24594997 http://dx.doi.org/10.1038/bjc.2014.71 |
Ejemplares similares
-
Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma
por: Patard, J-J, et al.
Publicado: (2009) -
Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma
por: Choi, Y, et al.
Publicado: (2013) -
Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma
por: Chang, Y, et al.
Publicado: (2015) -
Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009) -
Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma
por: Frödin, Magnus, et al.
Publicado: (2017)